First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commercial launch ...
Shares of India's IDFC First Bank slipped 15% on Monday, and were on course for their worst session in six years, after the private lender disclosed suspected fraudulent transactions worth 5.9 billion ...
Xeris Biopharma has strong revenue growth, with net product revenue reaching $203 million in 2024 and projected to hit $255–275 million in 2025. Key products include Gvoke for severe hypoglycemia, ...
SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc. ® is pleased to announce the commercial launch and availability of Gvoke VialDx™ (glucagon injection). Gvoke VialDx (glucagon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results